| Literature DB >> 36230183 |
Marina Pihurov1, Bogdan Păcularu-Burada1, Mihaela Cotârleț1, Gabriela Elena Bahrim1.
Abstract
Kombucha culture (named SCOBY-Symbiotic Culture of Bacteria and Yeasts) and milk kefir grains represent multiple consortia of wild microorganisms that include lactic acid bacteria, acetic acid bacteria and yeasts with valuable functional properties. Their fermentative potential provides a wide range of derivate metabiotics (prebiotics, probiotics, postbiotics and paraprobiotics) with valuable in vitro and in vivo benefits. This study targeted the evaluation of the functionality of a co-culture of SCOBY-based membranes and milk kefir grains, used as freeze-dried starter cultures, for the fermentation of a newly formulated medium based on black tea infusion, supplemented with bovine colostrum and sugar, in order to produce bioactive compounds with functional properties. The design and optimization of the biotechnological process were achieved by using the Plackett-Burman experimental design (six factorial points, three center points) and the response surface methodology and central composite design (three factorial points, six axial points and two center points in axial) tools. The statistical analysis and the mathematical modelling of the responses such as the pH, titratable acidity, antioxidant activity and antimicrobial activity (against Bacillus subtilis, Escherichia coli, Staphylococcus aureus and Aspergillus niger) were investigated. Further, the composition of organic acids, polyphenols and flavonoids of the fermented product obtained under the optimized fermentation conditions was also analyzed. The fermentation of the medium containing 6.27% (w/v) bovine colostrum powder, 1.64% (w/v) black tea, 7.5% (w/w) sugar, pH 6.7, with an inoculum based of 0.36% (w/v) milk kefir grains powder and 0.5% (w/v) SCOBY-based membrane (both as freeze-dried culture), at 30 °C, for 5 days, in an aerobic stationary system, revealed an antifungal activity between 80 and 100% against Aspergillus niger, an antibacterial activity of 8-22 mm against Escherichia coli and Bacillus spp. And a titratable acidity of 445 °Th. The chemical composition of the obtained product had a positive impact on the functional properties of the fermented products in terms of the antimicrobial and antioxidant properties.Entities:
Keywords: SCOBY-based membranes; bioactives; bioprocess optimization; co-fermentation; milk kefir grains
Year: 2022 PMID: 36230183 PMCID: PMC9563321 DOI: 10.3390/foods11193107
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Independent variables and their levels of variation established through the PB design.
| Independent Variables | Minimum Value, | Maximum Value, |
|---|---|---|
| 1.0 | 3.0 | |
| 5.0 | 10 | |
| 1.0 | 5.0 | |
| 5.0 | 7.0 | |
| 0.2 | 0.3 | |
| 0.2 | 0.3 |
Independent variables and their levels of variation in the CCD for RSM.
| Independent Variables | Levels of Variation | ||||
|---|---|---|---|---|---|
| −1 | 0 | +1 | −α | +α | |
| 1.0 | 2.0 | 3.0 | 0.367 | 3.633 | |
| 1.0 | 3.0 | 5.0 | −0.266 | 6.266 | |
| 0.1 | 0.2 | 0.3 | 0.0367 | 0.3633 | |
Design of the experiments by PB analysis and the obtained responses according to the variation of the independent variables.
| Sample | Independent Variables * | Responses | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | B | C | D | E | F | pH | Titratable | Antioxidant | Antibacterial Activity against | Antifungal | |
| 1 | 2.0 | 7.5 | 3.0 | 5.5 | 0.2 | 0.2 | 3.75 | 137.50 | 2.37 | 13.71 | 86.23 |
| 2 | 3.0 | 10.0 | 1.0 | 7.0 | 0.3 | 0.1 | 3.52 | 100.00 | 2.41 | 11.37 | 83.72 |
| 3 | 3.0 | 5.0 | 5.0 | 4.0 | 0.1 | 0.1 | 3.84 | 137.50 | 2.40 | 13.20 | 84.11 |
| 4 | 1.0 | 10.0 | 5.0 | 4.0 | 0.3 | 0.1 | 3.78 | 150.00 | 2.20 | 14.53 | 82.95 |
| 5 | 3.0 | 5.0 | 5.0 | 7.0 | 0.1 | 0.3 | 3.74 | 175.00 | 2.42 | 13.70 | 82.17 |
| 6 | 1.0 | 10.0 | 1.0 | 4.0 | 0.1 | 0.3 | 3.50 | 75.00 | 2.29 | 13.37 | 83.72 |
| 7 | 2.0 | 7.5 | 3.0 | 5.5 | 0.2 | 0.2 | 3.72 | 137.50 | 2.38 | 13.20 | 86.89 |
| 8 | 1.0 | 5.0 | 1.0 | 7.0 | 0.3 | 0.3 | 3.50 | 87.50 | 2.21 | 13.70 | 85.27 |
| 9 | 1.0 | 5.0 | 1.0 | 4.0 | 0.1 | 0.1 | 3.53 | 75.50 | 2.36 | 12.70 | 84.93 |
| 10 | 3.0 | 10.0 | 5.0 | 4.0 | 0.3 | 0.3 | 3.76 | 187.50 | 2.12 | 11.03 | 84.59 |
| 11 | 3.0 | 5.0 | 1.0 | 4.0 | 0.3 | 0.3 | 3.51 | 112.50 | 2.36 | 14.20 | 85.27 |
| 12 | 2.0 | 7.5 | 3.0 | 5.5 | 0.2 | 0.2 | 3.71 | 150.0 | 2.36 | 14.53 | 86.56 |
| 13 | 3.0 | 10.0 | 1.0 | 7.0 | 0.1 | 0.1 | 3.53 | 100.00 | 2.42 | 12.20 | 84.25 |
| 14 | 1.0 | 5.0 | 5.0 | 7.0 | 0.3 | 0.1 | 3.74 | 125.00 | 2.08 | 10.03 | 85.96 |
| 15 | 1.0 | 10.0 | 5.0 | 7.0 | 0.1 | 0.3 | 3.69 | 162.50 | 2.06 | 13.70 | 86.31 |
* A—Concentration of tea, % (w/v), B—Concentration of sugar, % (w/v), C—Concentration of colostrum, % (w/v), D—Fermentation time, days, E—Concentration of kombucha starter culture % (w/v), F—Concentration of milk kefir grains starter culture, % (w/v).
Figure 1The Pareto chart of the effect of the studied independent variables upon the acidity of the fermented products.
ANOVA analysis of variance for the TA.
| Source | DF | Adj SS | Adj MS | F-Value | |
|---|---|---|---|---|---|
| Model | 7 | 16285.7 | 2326.5 | 17.86 | 0.001 |
| Linear | 6 | 15536.6 | 2589.4 | 19.87 | 0.000 |
| Back tea concentration, % | 1 | 1564.1 | 1564.1 | 12.00 | 0.010 |
| Sugar concentration, % | 1 | 320.3 | 320.3 | 2.46 | 0.161 |
| Colostrum concentration, % | 1 | 12480.7 | 12480.7 | 95.79 | 0.000 |
| Time of fermentation, days | 1 | 12.0 | 12.0 | 0.09 | 0.770 |
| Kombucha starter culture | 1 | 114.1 | 114.1 | 0.88 | 0.381 |
| Milk kefir grains starter culture | 1 | 1045.3 | 1045.3 | 8.02 | 0.025 |
| Curvature | 1 | 749.1 | 749.1 | 5.75 | 0.048 |
| Error | 7 | 912.1 | 130.3 | ||
| Lack-of-Fit | 5 | 807.9 | 161.6 | 3.10 | 0.262 |
CCD and the analyzed responses in correlation with the independent variables variation.
| Run | Responses | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| A * | C | F | pH | Total activity, °Th | Antioxidant Activity, μM TE/mL | Antibacterial Activity against | Antibacterial Activity against | Antibacterial Activity against | Antifungal Activity against | |
| 1 | 1.00 | 1.00 | 0.30 | 3.55 | 225.00 | 1.30 | 2.17 | 0.00 | 10.50 | 93.73 |
| 2 | 2.00 | 3.00 | 0.20 | 3.71 | 229.37 | 2.01 | 4.00 | 0.14 | 10.05 | 92.95 |
| 3 | 2.00 | 3.00 | 0.20 | 3.80 | 220.00 | 2.12 | 1.83 | 0.00 | 8.55 | 93.15 |
| 4 | 3.00 | 1.00 | 0.30 | 3.71 | 100.00 | 2.47 | 0.00 | 0.00 | 4.83 | 100.00 |
| 5 | 1.00 | 5.00 | 0.30 | 3.49 | 344.80 | 1.94 | 6.50 | 3.83 | 18.50 | 100.00 |
| 6 | 1.00 | 5.00 | 0.10 | 3.79 | 212.62 | 1.31 | 2.67 | 3.52 | 14.50 | 93.38 |
| 7 | 3.00 | 5.00 | 0.30 | 3.76 | 250.00 | 2.44 | 3.50 | 0.00 | 10.33 | 100.00 |
| 8 | 1.00 | 1.00 | 0.10 | 3.38 | 229.00 | 1.35 | 2.50 | 0.00 | 11.75 | 90.76 |
| 9 | 2.00 | 3.00 | 0.20 | 3.72 | 234.20 | 2.01 | 4.00 | 0.00 | 11.12 | 92.98 |
| 10 | 3.00 | 5.00 | 0.10 | 3.86 | 187.50 | 2.35 | 0.00 | 0.00 | 8.17 | 90.41 |
| 11 | 2.00 | 3.00 | 0.20 | 3.82 | 215.60 | 2.07 | 2.66 | 0.00 | 7.95 | 94.23 |
| 12 | 3.00 | 1.00 | 0.10 | 3.65 | 193.75 | 2.72 | 2.00 | 0.00 | 7.83 | 100.00 |
| 13 | 2.00 | 3.00 | 0.20 | 3.76 | 243.75 | 2.14 | 2.50 | 0.00 | 9.55 | 93.68 |
| 14 | 3.63 | 3.00 | 0.20 | 3.80 | 150.00 | 2.41 | 0.00 | 0.00 | 6.67 | 100.00 |
| 15 | 2.00 | 6.27 | 0.20 | 3.71 | 308.20 | 2.08 | 5.50 | 3.20 | 16.00 | 100.00 |
| 16 | 2.00 | −0.27 | 0.20 | 3.41 | 225.00 | 2.23 | 2.00 | 0.00 | 8.91 | 100.00 |
| 17 | 2.00 | 3.00 | 0.20 | 3.83 | 206.25 | 2.16 | 3.35 | 0.00 | 9.02 | 93.54 |
| 18 | 2.00 | 3.00 | 0.36 | 3.74 | 212.50 | 2.20 | 2.83 | 0.00 | 7.67 | 100.00 |
| 19 | 2.00 | 3.00 | 0.03 | 3.89 | 162.50 | 2.18 | 1.83 | 0.00 | 7.17 | 91.40 |
| 20 | 0.37 | 3.00 | 0.20 | 3.47 | 238.80 | 0.91 | 5.18 | 3.44 | 16.23 | 96.03 |
* A—Concentration of black tea (%, w/v), C—Concentration of bovine colostrum (%, w/v), F—Concentration of milk kefir grains starter culture (%, w/v).
Figure 2Contour (left) and surface plots (right) correlation effects between the milk kefir grains starter culture’s concentration and the tea concentration upon the TA.
Model validation of the studied biotechnological parameters for the optimized fermented product.
| Response | Predicted Value | Experimental Value |
|---|---|---|
| Titratable acidity, °Th | 434.50 | 456.25 ± 0.16 |
| Antioxidant activity, μM TE/ mL | 2.45 | 2.42 ± 0.01 |
| Antibacterial activity against | 9.50 | 8.67 ± 0.10 |
| Antibacterial activity against | 5.07 | 8.00 ± 0.22 |
| Antibacterial activity against | 21.98 | 21.67 ± 0.10 |
| Composite desirability | 0.95 |
The organic acids’ concentrations after the medium fermentation based on bovine colostrum, black tea and sugar with milk kefir grains and freeze-dried kombucha membrane starter culture, under optimized conditions.
| Organic Acids | Concentration, mg/mL | |
|---|---|---|
| Control Sample | Fermented Product | |
| Lactic acid | 7.77 ± 2.14 b | 24.39 ± 0.04 a |
| Citric acid | ND * | 5.77 ± 0.01 a |
| Acetic acid | 9.14 ± 0.00 b | 25.21 ± 0.10 a |
| Butyric acid | 81.63 ± 0.07 a | 67.33 ± 0.05 b |
| Isovaleric acid | 4.36 ± 0.01 a | 4.36 ± 0.01 a |
Different letters in a row denote significant differences between the control and the fermented product (p < 0.05). * ND—Not Detectable.
Phenolic acids and flavonoids’ content of the fermented product obtained under optimized biotechnological conditions.
| Bioactive Compounds | Control Sample, µg/mL | Optimized Sample, µg/mL | ||
|---|---|---|---|---|
| 280 nm | 320 nm | 280 nm | 320 nm | |
| Gallic acid | 170.51 ± 5.73 a | 27.71 ± 0.08 A | 71.40 ± 4.82 b | 7.52 ± 2.34 B |
| Epicatechin | ND | ND | 1062.69 ± 53.50 a | 347.84 ± 50.81 A |
| Caffeic acid | 464.45 ± 49.00 a | 97.16 ± 1.44 A | 314.86 ± 28.10 b | 7.79 ± 2.14 B |
| Chlorogenic acid | 54.66 ± 8.11 a | ND | ND | ND |
| p-Coumaric acid | 28.89 ± 0.11 a | ND | ND | ND |
| Quercetin | ND | ND | 18.20 ± 0.02 a | ND |
| Apigenin | ND | ND | 0.22 ± 0.00 a | ND |
| Isorhamnetin | 4.60 ± 0.10 a | ND | 2.97 ± 0.03 b | ND |
| Kaempferol | 282.30 ± 28.09 a | 9.78 ± 1.00 A | ND | ND |
Different lowercase letters in a row denote significant differences between the control and the optimized sample at 280 nm, whereas the different uppercase letters in a row denote the significant differences between the control and the optimized sample at 320 nm (p < 0.05).